Press Release: Mexedia S.p.A. Società Benefit: Approval of the Draft Statutory and Consolidated Financial Statements as of December 31, 2025

Dow Jones03-31
ROME--(BUSINESS WIRE)--March 30, 2026-- 

Regulatory News:

The Board of Directors of Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819), meeting today, approved the draft statutory financial statements and the consolidated financial statements for the year ended December 31, 2025.

Consolidated revenues at EUR118.1 million (+62.0% compared to EUR72.9 million in 2024)

Gross margin at EUR10.2 million (+38.2% compared to EUR7.4 million in 2024)

EBITDA at EUR-1.2 million (improving from EUR-23.4 million in 2024)

Net result at EUR-21.2 million (+20.3% compared to EUR-26.7 million in 2024)

Net financial position at EUR-34.7 million (improving from EUR-47.6 million in 2024)

2025 Results (values in EUR thousand)

 
                                    2025     2024 
            Revenues               118,086  72,899 
          Gross margin             10,223    7,400 
             EBITDA                -1,243   -23,418 
    Profit (loss) before tax       -31,051  -27,834 
Net profit (loss) for the period   -21,236  -26,656 
          Total assets             186,065  157,518 
             Equity                26,472   40,712 
     Net financial position        -34,734  -47,635 
 

Mr. Elio Catania, Chairman of Mexedia S.p.A. Società Benefit, commented: <<2025 represents a significant step in the Group's evolution. During the year, we operated with discipline in rationalizing the Group's scope and focusing our activities, defining a more efficient and sustainable structure. The results highlight clear signs of improvement and confirm the validity of the strategic choices made, laying the foundations for a progressive strengthening of the Group's economic and financial balance and for development increasingly focused on the quality of profitability. We look ahead with a more focused operating model and with the objective of creating long-term value, maintaining an approach based on prudence, responsibility and disciplined management.>>

This is complemented by a statement from Paolo Bona, Chief Executive Officer of Mexedia S.p.A. Società Benefit: "Throughout 2025, we worked consistently on improving the efficiency of our operating structure and enhancing the quality of revenues, taking targeted actions on costs and working capital management. The results show a significant recovery in operating performance and confirm that the actions undertaken are delivering tangible effects, in line with our objectives. In the short to medium term, we intend to continue along this path, with a primary focus on achieving economic and financial balance, generating margins and consolidating our activities, while maintaining a disciplined approach in execution and in the selection of growth opportunities."

Financial and business overview

The 2025 results show significant revenue growth and an improvement in operating performance compared to the previous year.

EBITDA, although still negative, shows a substantial improvement, reflecting cost optimization measures and the recovery of operational activity.

The net financial position improved compared to 2024, while equity reflects the economic dynamics of the year.

The results for the year reflect the reorganization process launched in 2024, the consequent evolution of the operating perimeter and the progressive recovery in activity levels, with signs of a strengthening in the Group's economic and financial solidity.

In 2025, the Group recorded increased volumes and improved operational efficiency, with positive effects on overall economic performance.

The Group intends to continue strengthening its operational structure and consolidating its activities, maintaining a disciplined and sustainable approach over time, with particular focus on:

   --  improving the quality of revenues; 
 
   --  optimizing the cost structure; 
 
   --  disciplined management of working capital; 
 
   --  progressive strengthening of economic and financial fundamentals. 

Upcoming events

The Shareholders' Meeting for the approval of the Financial Statements as at 31 December 2025 is convened on 27 April 2026 on first call and, if necessary, on 28 April 2026 on second call.

The Consolidated Annual Financial Report as of December 31, 2025 will be made available to the public in the "Financial Statements and Reports" section of the Company's website starting from April 28, 2026:

https://mexedia.com/en/financial-statements-and-reports/

Statement pursuant to Article 154-bis of the TUF

The executive responsible for preparing the Company's financial reports, Daniel Gilcher, certifies -- pursuant to Article 154-bis, paragraphs 3 and 4, of Legislative Decree No. 58/1998 -- the adequacy and effective application of administrative and accounting procedures in the preparation of the consolidated financial statements as of December 31, 2025.

Forward-looking statements $(MAR)$

This press release may contain forward-looking statements pursuant to Regulation $(EU)$ No. 596/2014 ("MAR") and other applicable regulations. Such statements reflect current expectations and projections regarding future events and are subject to risks and uncertainties that may cause actual results to differ materially.

About Mexedia

Mexedia S.p.A. Società Benefit is a technology company listed on Euronext Growth Paris (ISIN: IT0005450819, ticker: ALMEX) since September 22, 2021, active in technology services and communication solutions. The Group operates internationally and develops industrial models focused on long-term value creation. As a Società Benefit, Mexedia integrates economic growth objectives with social and environmental impact goals, pursuing sustainable value creation over time.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260330988763/en/

 
    CONTACT: 

Investor Relations

Vincenzo La Barbera

investor.relations@mexedia.com

+39 3518447229

 
 

(END) Dow Jones Newswires

March 30, 2026 12:05 ET (16:05 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment